RecruitingNCT04402086
Rheumatology Patient Registry and Biorepository
Sponsor
Yale University
Enrollment
5,000 participants
Start Date
Aug 4, 2020
Study Type
OBSERVATIONAL
Conditions
Rheumatoid ArthritisLyme DiseaseSarcoidosisAnkylosing SpondylitisSclerodermaPsoriatic ArthritisReactive ArthritisSystemic Lupus ErythematosusDermatomyositisSjogren's SyndromePolymyositisSystemic SclerosisAntiphospholipid SyndromeBehcet DiseaseRheumatic DiseasesAdult Onset Still DiseaseGiant Cell ArteritisMixed Connective Tissue DiseasePolymyalgia RheumaticaUndifferentiated Connective Tissue Diseases
Summary
To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Plain Language Summary
Simplified for easier understanding
This is a patient registry and tissue collection study at Yale for people with rheumatic autoimmune diseases — conditions where the immune system mistakenly attacks the body's own tissues. Researchers will collect health information and optional tissue samples to better understand these diseases.
**You may be eligible if...**
- You are 18 or older
- You have been diagnosed with a rheumatic autoimmune disease (such as lupus, rheumatoid arthritis, scleroderma, psoriatic arthritis, Sjögren's syndrome, or similar conditions)
- You receive care at Yale Rheumatology clinics
- Healthy volunteers aged 18+ with no autoimmune disease are also welcome
**You may NOT be eligible if...**
- You cannot give informed consent
- You are allergic to lidocaine or epinephrine (if a skin biopsy is involved)
- You have a history of poor wound healing (if a skin biopsy is involved)
- Healthy volunteers: you must have a normal BMI and no chronic skin conditions
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04402086
Related Trials
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
NCT06617325225 locations
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
NCT000015391 location
Study of Systemic Lupus Erythematosus
NCT000013721 location
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
NCT0688819312 locations
Environmental Risk Factors for the Anti-synthetase Syndrome
NCT012764708 locations